MED 7 LLC AND HEMPCO IC. ANNOUNCE THE PUBLICATION OF THE FIRST PROSPECTIVE HUMAN CLINICAL TRIAL USING A CBD-RICH FULL-SPECTRUM HEMP OIL IN PATIENTS WITH COVID-19

Bluffdale, UT, May 12, 2022 – Med 7, LLC (www.Med 7cbd.com), and HempCo, Inc., Lone Tree, CO, announce the completion and publication of the first prospective human clinical study to assess the effects of a CBD-rich full-spectrum hemp oil in patients with COVID-19 (SARS-CoV-2). The study used Med 7, a full-spectrum hemp product made with Purzorb® technology, now trademarked as Hempzorb81™.

Read More »

MED 7, LLC ANNOUNCES GRANT OF US PATENT FOR CLINICAL USE.

BLUFFDALE, Utah, January 15, 2024 — Med 7, LLC (www.med7cbd.com) announces the recent granting of a US patent for Hempzorb81™,

Med 7 LLC, announces the completion of a Sleep Study using Hempzorb81™ Full Spectrum Hemp Oil

BLUFFDALE, Utah, Oct. 1, 2021 /PRNewswire/ — Med 7, LLC (www.Med 7cbd.com) and HempCo, Inc. announce the completion of a human clinical

Med 7 Healing Gel is the Big Gun!

  Forbes: A Complete Guide to Summer’s Best Skincare Essentials In 2021, Med 7 Healing Gel made it into Forbes

Med 7 llc, announce the completion of a safety and efficacy study using hempzorb81™ full spectrum oil in patients with type ii diabetes

BLUFFDALE, Utah, April 29, 2021 /CNW/ — Med7, LLC (www.Med7cbd.com) and HempCo, Inc. announce the completion of a human clinical study in patients

PurHealthRX® Announces Completion of the First Major Non-pharmaceutical CBD Study in Humans

LAS VEGAS, NV – PurHealthRX® announced the completion of the first major clinical study looking at the anti-aging effects and